Genetic determinants of phenotype in beta-thalassemia

Hematology

Volumn 13, Issue 4, 2008, Pages 247-252

  Panigrahi, Inusha ^a   Agarwal, Sarita ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Genes; Genotype phenotype; Modifiers; Mutations; Thalassemia syndromes

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN F; HYDROXYUREA;

BETA THALASSEMIA; BONE DISEASE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE SEVERITY; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; IRON OVERLOAD; JAUNDICE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; THROMBOSIS; TRANSFUSION;

BETA-GLOBINS; BETA-THALASSEMIA; FETAL HEMOGLOBIN; HUMANS; MUTATION; PHENOTYPE;

EID: 55849129568     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453308X316031     Document Type: Review

References (44)

1. Higgs DR, Thein SL, Wood WG. Distribution and population genetics of the thalassemias. In: Weatherall DJ, Clegg JB. (eds) The thalassemia syndromes. 4th ed. Oxford: Blackwell Science, 2001; 237-284.
2. Wong C, Antonarkis SE, Goff SC, Orkin SH, Boehm CD, Kazazian HH. On the origin and spread of β-thalassemia: Recurrent observation of four mutations in different ethnic groups. Proc. Natl. Acad Sci USA 1986; 83: 6529-6532.
3. Nadkarni A, Gorashaker AC, Lu CY et al. Molecular pathogenesis and clinical variability of β-thalassemia syndromes among Indians. Am J Hematol 2001; 68: 75-80.
4. Camaschella C, Maza U, Roetto A et al. Genetic interactions in thalassemia intermedia: Analysis of beta-mutations, alpha-genotype, gamma-promoters, and beta-LCR hypersensitive sites 2 and 4 in Italian patients. Am J Hematol 1995; 48: 82-87.
5. Galanello R, Piras S, Barella S et al. Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassaemia. Br J Haematol 2001; 115(4): 926-928.
6. Cappellini MD, Fargion SR, Sampietro M, Graziadei G, Fiorelli G. Non-transfusional iron overload in thalassemia intermedia: Role of the hemochromatosis allele. Blood 1998; 92(11): 4479-4480
7. Bank A. Regulation of human fetal hemoglobin: New players, new complexities. Blood 2006; 107: 435-443.
8. Tolhuis B, Palstra RJ, Splinter E, Grosveld F, de Laat W. Looping and interaction between hypersensitive sites in the active β-globin locus. Mol Cell 2002; 10: 1453-1465.
9. Cimbora DM, Schubeler D, Reik A et al. Long-distance control of origin choice and replication timing in the human β-globin locus are independent of the locus control region. Mol Cell Biol 2000; 20: 5581-5591.
10. Chehab FF, Honig GR, Kan YW. Spontaneous mutation in beta-thalassaemia producing the same nucleotide substitution as that in a common hereditary form. Lancet 1986; 1(8471): 3-5.
11. Thein SL. Structural variants with a β-thalassemia phenotype. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL. (eds) Disorders of hemoglobin: Genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press, 2001; 342-355.
12. Panigrahi I, Agarwal S, Gupta T, Singhal P, Pradhan M. Hemoglobin E-beta thalassemia: Factors affecting phenotype. Indian Pediatr 2005; 42(4): 357-362.
13. Efremov GD. Dominantly Inherited beta-Thalassemia. Hemoglobin 2007; 31(2): 193-207.
14. Faustino P, Osório-Almeida L, Romäo L et al. Dominantly transmitted beta-thalassemia arising from the production of several aberrant mRNA species and one abnormal peptide. Blood 1998; 91(2): 685-690.
15. Garewal G, Das, R, Ahluwalia J, Marwaha, RK, Varma S. Nucleotide-88 (C-T) promoter mutation is a common beta-thalassemia muttion in the Sikhs of Punjab, India. Am J Hematol 2005; 79(4): 252-256.
16. Shaji RV, Eunice SE, Baidya S, Srivastava A, Chandy M. Determination of the breakpoint and molecular diagnosis of a common alpha-thalassaemia-1 deletion in the Indian population. Br J Haematol 2003; 123(5): 942-947.
17. + thalassemia in two tribal populations from Andhra Pradesh, India. Human Genetics 1988; 80: 157-160.
18. Panigrahi I, Agarwal S, Pradhan M, Choudhry DR, Choudbry VP, Saxena R. Molecular characterization of thalassemia intermedia in Indians. Haematologica. 2006; 91(9): 1279-1280.
19. Bandyopadhyay, S, Roychowdhury K, Chandra S, Das M, Dasgupta UB. Variable severity of beta-thalassemia patients of eastern India: Effect of alpha-thalassemia and XmnI polymorphism. Clin Exp Med 2001; 1(3): 155-159.
20. Garewal G, Clair W, Fearon CW et al. The molecular basis of β-thalassaemia in Punjabi and Maharastrian Indians includes a multilocus etiology involving triplicated alpha-globin gene loci. Br J Haematol 1994; 86: 372-376.
21. Ma SK, Au WY, Chan AY, Chan LC. Clinical phenotype of triplicated alpha-globin genes and heterozygosity for beta0-thalassemia in Chinese subjects. Int J Mol Med 2001; 8(2): 171-175.
22. Bianco I, Lerone M, Foglietta E et al. Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication. Haematologica 1997; 82(5): 513-525.
23. Craig JE, Rochette J, Fisher CA et al. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nature Genetics 1996; 12: 58-64
24. Dover GJ, Smith KD, Chang YC et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22-2. Blood 1992; 80: 816-824.
25. Garner C, Tatu T, Best S, Creary L, Thein SL. Evidence for genetic interaction between the β-globin complex and chromosome 8q in the expression of fetal hemoglobin. Am J Hum Genet 2002; 70: 793-799.
26. Papachatzopoulou A, Kourakli A, Makropoulou P et al. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF β-thalassemia intermedia. Eur J Haematol 2006; 76: 322-330.
27. Fucharoen S, Fucharoen G, Sanchaisuriya K, Surapot S. Molecular characterization of thalassemia intermedia associated with HPFH-6/ beta-thalassemia and HPFH-6/HbE in Thai patients. Acta Haematol 2002; 108:(3):157-161.
28. Tzetis M, Kanavakis E, Tsezou A et al. Gilbert syndrome associated with beta-thalassemia. Pediatr Hematol Oncol 2001; 18(8): 477-484.
29. Galanello R, Cippolina MD, Dessi C, Giagu N, Cao A. Co-inherited Gilbert's syndrome: A factor determining hyperbilirubinemia in homozygous β-thalassemia. Haematologica 1999; 84: 103-105.
30. Borgna-Pignatti C, Rigon F, Merlo L et al. Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Haematologica 2003; 88(10): 1106-1109.
31. Panigrahi I, Mahapatra M, Kumar R, Kumar G, Choudhry VP, Saxena R. Jaundice and alpha gene triplication in beta-thalassemia: Association or causation? Hematology 2006; 11(2): 109-112.
32. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-278.
33. Ruiz-Arguelles GJ, Garces-Eisele J, Reyes-Nunez V et al. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred. Rev Invest Clin 2001; 53(2): 117-120.
34. Piperno A, Mariani R, Arosio C et al. Haemochromatosis in patients with β-thalassaemia trait. Br J Haematol 2000; 111: 908-914.
35. Melis MA, Cau M, Deidda F, Barella S, Cao A, Galanello, R. H63D mutation in the HFE gene increases iron overload in β-thalassemia carriers. Haematologica 2002; 87: 242-245.
36. Garewal G, Das R, Ahluwalia J, Marwaha RK. Prevalence of the H63D mutation of the HFE in north India: Its presence does not cause iron overload in beta thalassemia trait. Eur J Haematol 2005; 74(4): 333-336.
37. Sharma V, Panigrahi I, Dutta P, Tyagi S, Choudhry VP, Saxena R. HFE mutation H63D predicts risk of iron over load in thalassemia intermedia irrespective of blood transfusions. Indian J Pathol Microbiol 2007; 50(1): 82-85.
38. Voskaridou E, Kyrtsonis MC, Terpos E et al. Bone resorption is increased in young adults with thalassaemia major. Br J Haematol 2001, 112(1): 36-41.
39. Lasco, W, Morabito N, Gaudio A et al. Osteoporosis and beta-thalassemia major: Role of the IGF-I/IGFBP-III axis. J Endocrinol Invest 2002; 25(4): 338-344.
40. Perrotta S, Cappellini MD, Bertoldo, F et al. Osteoporosis in β-thalassaemia major patients: Analysis of the genetic background. Br J Haematol 2000; 111: 461-466.
41. Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with β-thalassaemia major and intermedia. Br J Haematol 2000; 111: 902-907.
42. Economou-Peterson E, Aesspopos A. Kladi A et al. Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous β-thalassemia. Blood 1998; 92: 3455-3459.
43. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability ill splenectomized patients with thalassaemia intermedia. Br J Haematol 2000; 111: 467-473.
44. Panigrahi I, Agarwal S. Thromboembolic complications in beta-thalassemia: Beyond the horizon. Thromb Res 2007; 120: 783-789.